Manejo Conservador de Retención de Productos de la Concepción con Anticonceptivos Orales Combinados. Presentación de Caso Conservative Management of Retained Products of Conception with Combined Oral Contraceptives. Case Report

Contenido principal del artículo

Bayron Manuel Ruiz Hoyos
https://orcid.org/0000-0002-8237-4553

Resumen

RESUMEN


Objetivo: presentar el caso de una paciente con retención de productos de la concepción (RPC) después de aborto médico, tratada con anticonceptivos orales combinados (ACOC), y efectuar revisión de la literatura. Caso Clínico: paciente de 37 años, con sangrado genital escaso y leve dolor pélvico, quien tuvo aborto provocado con misoprostol cuatro días antes, acude sin signos de infección, con endometrio mixto de 18,5 mm. Durante seis semanas de seguimiento persiste sangrado y endometrio mixto engrosado, con disminución lenta de la gonadotrofina corionica humana (GCH); se sospecha RPC, se suministra ciclo de ACOC y al terminarlos expulsa completamente el tejido retenido. Metodología: búsqueda bibliográfica en bases de datos Google Scholar, Science Direct, RIMA, PubMed. Revisión de literatura: la RPC se presenta después de parto o aborto (más frecuente). Criterios diagnósticos: sangrado persistente, hallazgos ecográficos y medición de GCH. Diagnóstico diferencial: enfermedad trofoblastica gestacional y malformaciones arteriovenosas uterinas. Es factible el manejo conservador, con bajas tasas de infección o procedimientos quirúrgicos. Ante la evolución prolongada, presencia de signos de infección o hemorragia importante, se impone la evacuación quirúrgica, tradicionalmente con dilatación y legrado, y más recientemente resección histeroscópica. La bibliografía reciente sugiere el uso de ACOC como manejo médico. En nuestro caso, la paciente tomó un ciclo de ACOC y al terminarlos presentó expulsión de los restos retenidos. Conclusiones: el manejo conservador de la RPC con ACOC surge como una opción en casos seleccionados; son necesarios estudios controlados para definir su utilidad.
Palabras clave: misoprostol, aborto incompleto, anticonceptivos orales combinados.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Sección
Artículos Reportes de Caso
Biografía del autor/a

Bayron Manuel Ruiz Hoyos, Universidad del Quindío

Medico Ginecoobstetra, Magister en Educación, Profesor Asociado, Universidad del Quindío. Armenia, Colombia.

Citas

Debby A, Malinger E, Harow E, Golan A, Glezerman M. Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception. Ultrasound Obstet Gynecol. 2006; 27(1):61-64. DOI: 10.1002/uog.2654

, Ben-Ami I, Melcer Y, Smorgick N, Schneider D, Pansky M, Halperin R. A comparison of reproductive outcomes following hysteroscopic management versus dilatation and curettage of retained products of conception, Int J Gynecol Obstet. 2014; 127(1):86-89. http://dx.doi.org/10.1016/j.ijgo.2014.05.003

Hooker AB, Aydin H, Brôlmann HA, Huirne JA. Long term complications and reproductive outcome after the management of retained products of conception: a systematic review. Fertility and Sterility. 2016; 105(1):156-164. https://doi.org/10.1016/j.fertnstert.2015.09.021

Klement AH, Frederic M, Bentov Y, Chang P, Nayot D, Haas J, et al. Oral contraceptive pills as an option for non-surgic al management of retained products of conception-a preliminary study. Gynecol Endocrinol. 2018; 34(7):609-611. DOI: 10.1080/09513590.2018.1427714

Jimenez JS, Gonzalez C, Alvarez C, Muñoz L, Perez C, Muñoz J. Conservative management of retained trophoblastic tissue and placental polyp with diagnostic ambulatory hysteroscopy. Eur J Obstet Gynecol Reprod Biol. 2009; 145(1): 89–92. https://doi.org/10.1016/j.ejogrb.2009.04.001

Harish KM, Shwetha N, Dipankar D. Comparative análisis of hysteroscopy versus suction evacuation in the management of retained products of conception. Int J Reprod Contracept Obstet Gynecol. 2018; 7(6):2155-2159. http://dx.doi.org/10.18203/2320-1770.ijrcog20182009

Sellmyer MA, Desser TS, Maturen KE, Jeffrey RB, Kamaya A. Physiologic, Histologic, and Imaging Features of Retained Products of Conception. Radiographics. 2013; 33(3):781-796. DOI: 10.1148/rg.333125177

Casikar I, Bignardi T, Riemke J, Alhamdan D, Condous G. Expectant management of spontaneous first-trimester miscarriage: pospective validation of the “2 weeks rule”. Ultrasound Obstet Gynecol. 2010; 35(2): 223–227. DOI: 10.1002/uog.7486

Trinder J, Brocklehurst P, Porter R, Read M, Vyas S, Smith L. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ. 2006; 332(7552):1235-1240. DOI: 10.1136/bmj.38828.593125.55

Barnhart K, Sammel MD, Chung K, Zhou L, Hummel AC, Guo W. Decline of Serum Human Chorionic Gonadotropin and Spontaneous Complete Abortion: defining the Normal Curve. Obstet Gynecol. 2004; 104(5) 975-981. DOI: 10.1097/01.AOG.0000142712.80407.fd

Pocius KD, Maurer R, Fortin J, Goldberg AB, Bartz D. Early serum human chorionic gonadotropin (hCG) trends after medication abortion. Contraception. 2015; 91(6): 503–506. DOI: 10.1016/j.contraception.2015.03.004

Pourali L, Ayati S, Layegh P, Vatanchi A, Rastin Z, Shourvi A. Persistent low levels of Beta-hCG: a pitfall in diagnosis of Retained products of Conception. Acta Med Iran. 2018; 56(7):478-481.

Tohma YA, Dilbaz B, Evliyaoğlu O, Çoşkun B, Çolak E, Dilbaz S. Is ultrasonographic evaluation essential for diagnosis of retained products of conception after surgical abortion? J Obstet Gynaecol Res. 2016; 42(5):489-495. https://doi.org/10.1111/jog.12944

Reeves MF, Fox MC, Lohr PA, M. D. Creinin MD. Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound Obstet Gynecol. 2009; 34(1):104–109. DOI: 10.1002/uog.6404

Sawyer E, Ofuasia E, Ofili-Yebovi D, Helmy S, Gonzalez J, Jurkovic D. The value of measuring endometrial thickness and volumen on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol. 2007; 29(2):205–209. DOI: 10.1002/uog.3914

Chopra N, Kaur M, Kaur-Mohi M. Correlation of ultrasound with histopathology for retained products of conception in medically managed abortions. Int J Reprod Contracept Obstet Gynecol. 2017; 6(8):3372-3375. http://dx.doi.org/10.18203/2320-1770.ijrcog20173373

Hameed BH. Incomplete miscarriage, expectant versus medical management and the use of Doppler sonography for patient selection. Iraqi J Comm Med. 2016; 2:10-15.

Van den Bosch T, Van Schoubroeck D, Timmerman D. Maximum Peak Systolic Velocity and Management of Highly Vascularized Retained Products of Conception. J Ultrasound Med. 2015; 34(9):1577–1582. DOI: 10.7863/ultra.15.14.10050

Betel C, Atri M, Arenson AM, Khalifa M, Osborne R, Tomlinson G. Sonographic Diagnosis of Gestational Trophoblastic Disease and Comparison With Retained Products of Conception. J Ultrasound Med. 2006; 25(8):985–993. DOI: 10.7863/jum.2006.25.8.985

Jain K, Fogata M. Retained Products of Conception Mimicking a Large Endometrial AVM: Complete Resolution Following Spontaneous Abortion. J Ultrasound Med. 2007; 35(1):42-47. DOI: 10.1002/jcu.20250

Vilos AG, Vilos GA, Hollett-Caines J, Rajakumar C, Garvin G, Kozack R. Uterine artery embolization for uterine arteriovenous malformation in five women desiring fertility: pregnancy outcomes. Hum Reprod. 2015; 30(7):1599–1605. DOI: 10.1093/humrep/dev097

Hashim H, Nawawi O. Uterine arteriovenous malformation. Malays J Med Sci. 2013; 20(2):76-80.

Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017; 1:1-2. DOI: 10.1002/14651858.CD007223.pub4

Lemmers M, Verschoor MA, Regenrink KO, Naaktgeboren C, Opmeer BC, Bossuyt PM, et al. MisoREST: surgical versus expectant management in women with an incomplete evacuation of the uterus after misoprostol treatment for miscarriage: a randomized controlled trial. Hum Reprod. 2016; 31(11):2421-2427. DOI:10.1093/humrep/dew221

Kaviani M, Tehrani TA, Azima S, Abdali K, Asadi N. Comparison of the Effects of Simultaneous Use of Methylergonovine and Combined Low-dose (LD) Contraceptive Pills on Hemorrhage Due to Retained Pregnancy Products after Abortion. Int J Curr Microbiol App Sci. 2016; 5(11):499-507. http://dx.doi.org/10.20546/ijcmas.2016.511.058

Lethaby A, Wise MR, Weterings MA, Bofill-Rodriguez M, Brown J. Combined hormonal contraceptives for heavy menstrual bleeding. Cochrane Database Syst Rev. 2019;2:1-3. DOI: 10.1002/14651858.CD000154.pub3

Martin CW, Brown AH, Baird DT. A pilot study of the effect of methotrexate or combined oral contraceptive on bleeding patterns after induction of abortion with mifepristone and a prostaglandin pessary. Contraception. 1998; 58(2):99-103. DOI: 10.1016/s0010-7824(98)00072-9

Smorgick N, Barel O, Fuchs N, Ben-Ami I, Pansky M, Vaknin Z. Hysteroscopic management of retained products of conception: meta-analysis and literature review. Eur J Obstet Gynecol Reprod Biol. 2014; 173:19–22. https://doi.org/10.1016/j.ejogrb.2013.11.020